These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25662347)

  • 21. CD39
    Shen M; Lim JME; Chia C; Ren EC
    Immunobiology; 2020 Jan; 225(1):151868. PubMed ID: 31784043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
    Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
    Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T regulatory cells lacking CD25 are increased in MS during relapse.
    Fransson M; Burman J; Lindqvist C; Atterby C; Fagius J; Loskog A
    Autoimmunity; 2010 Dec; 43(8):590-7. PubMed ID: 20370571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
    Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
    Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
    Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
    Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high-dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse.
    Liu M; Hu X; Wang Y; Peng F; Yang Y; Chen X; Lu Z; Zheng X
    Acta Neurol Scand; 2009 Oct; 120(4):235-41. PubMed ID: 19769778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
    Caragnano M; Tortorella P; Bergami A; Ruggieri M; Livrea P; Specchio LM; Martino G; Trojano M; Furlan R; Avolio C
    J Neuroimmunol; 2012 Apr; 245(1-2):93-7. PubMed ID: 22370183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD39/Entpd1 on granuloma-composing cells and induction of Foxp3-positive regulatory T cells in sarcoidosis.
    Fujimura T; Kambayashi Y; Aiba S
    Clin Exp Dermatol; 2013 Dec; 38(8):883-9. PubMed ID: 24252080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
    Telesford KM; Yan W; Ochoa-Reparaz J; Pant A; Kircher C; Christy MA; Begum-Haque S; Kasper DL; Kasper LH
    Gut Microbes; 2015 Jul; 6(4):234-42. PubMed ID: 26230152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.
    Jin X; Zhang C; Gong L; Li H; Wang Y; Li Q; Li H
    J Diabetes; 2019 Jun; 11(6):440-448. PubMed ID: 30318734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
    Schulze Zur Wiesch J; Thomssen A; Hartjen P; Tóth I; Lehmann C; Meyer-Olson D; Colberg K; Frerk S; Babikir D; Schmiedel S; Degen O; Mauss S; Rockstroh J; Staszewski S; Khaykin P; Strasak A; Lohse AW; Fätkenheuer G; Hauber J; van Lunzen J
    J Virol; 2011 Feb; 85(3):1287-97. PubMed ID: 21047964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
    De Andres C; García MI; Goicoechea H; Martínez-Ginés ML; García-Domínguez JM; Martín ML; Romero-Delgado F; Benguría A; Sanjurjo M; López-Fernández LA
    Pharmacogenomics J; 2018 Jan; 18(1):98-105. PubMed ID: 27670768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Katia Patanella A; Bianco A; Caggiula M; Sancricca C; Tonali PA; Mirabella M; Batocchi AP
    Clin Immunol; 2007 Sep; 124(3):284-93. PubMed ID: 17627892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
    Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CM; Pett S; Ananworanich J; Zaunders J; Kelleher AD
    Eur J Immunol; 2014 Jun; 44(6):1644-61. PubMed ID: 24752698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.
    Ye ZJ; Zhou Q; Zhang JC; Li X; Wu C; Qin SM; Xin JB; Shi HZ
    Respir Res; 2011 Jun; 12(1):77. PubMed ID: 21663645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.